Skip to content

Author

Gargi Mukherjee

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS‐CoV‐2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir

Data is presented showing that 17AAG covalently binds to the active‐site cysteine of Mpro, disrupts its secondary structure, and protects cells from Mpro‐induced toxicity more effectively than nirmatrelvir.

Gargi Mukherjee, Shayantani Chakraborty, Anshuman Chandra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.